Structural basis of Cas3 activation in type I-C CRISPR-Cas system

被引:1
|
作者
Kim, Do Yeon [1 ,2 ]
Lee, So Yeon [1 ,2 ]
Ha, Hyun Ji [1 ]
Park, Hyun Ho [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
[2] Chung Ang Univ, Grad Sch, Dept Global Innovat Drugs, Seoul 06974, South Korea
基金
新加坡国家研究基金会;
关键词
PROVIDES ACQUIRED-RESISTANCE; INTERFERENCE; BACTERIA; NUCLEASE; INSIGHTS; IMMUNITY; HELICASE; TOOL;
D O I
10.1093/nar/gkae723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas systems function as adaptive immune mechanisms in bacteria and archaea and offer protection against phages and other mobile genetic elements. Among many types of CRISPR-Cas systems, Type I CRISPR-Cas systems are most abundant, with target interference depending on a multi-subunit, RNA-guided complex known as Cascade that recruits a transacting helicase nuclease, Cas3, to degrade the target. While structural studies on several other types of Cas3 have been conducted long ago, it was only recently that the structural study of Type I-C Cas3 in complex with Cascade was revealed, shedding light on how Cas3 achieve its activity in the Cascade complex. In the present study, we elucidated the first structure of standalone Type I-C Cas3 from Neisseria lactamica (NlaCas3). Structural analysis revealed that the histidine-aspartate (HD) nuclease active site of NlaCas3 was bound to two Fe2+ ions that inhibited its activity. Moreover, NlaCas3 could cleave both single-stranded and double-stranded DNA in the presence of Ni2+ or Co2+, showing the highest activity in the presence of both Ni2+ and Mg2+ ions. By comparing the structural studies of various Cas3 proteins, we determined that our NlaCas3 stays in an inactive conformation, allowing us to understand the structural changes associated with its activation and their implication. Graphical Abstract
引用
收藏
页码:10563 / 10574
页数:12
相关论文
共 50 条
  • [31] Exploring the success of Brazilian endemic clone Pseudomonas aeruginosa ST277 and its association with the CRISPR-Cas system type I-C
    Melise Chaves Silveira
    Cláudio Marcos Rocha-de-Souza
    Rodolpho Mattos Albano
    Ivson Cassiano de Oliveira Santos
    Ana Paula D’Alincourt Carvalho-Assef
    BMC Genomics, 21
  • [32] The structural biology of CRISPR-Cas systems
    Jiang, Fuguo
    Doudna, Jennifer A.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2015, 30 : 100 - 111
  • [33] Highly efficient genome editing in Xanthomonas oryzae pv. oryzae through repurposing the endogenous type I-C CRISPR-Cas system
    Jiang, Dandan
    Zhang, Dandan
    Li, Shengnan
    Liang, Yueting
    Zhang, Qianwei
    Qin, Xu
    Gao, Jinlan
    Qiu, Jin-Long
    MOLECULAR PLANT PATHOLOGY, 2022, 23 (04) : 583 - 594
  • [34] Exploring the success of Brazilian endemic clone Pseudomonas aeruginosa ST277 and its association with the CRISPR-Cas system type I-C
    Silveira, Melise Chaves
    Rocha-de-Souza, Claudio Marcos
    Albano, Rodolpho Mattos
    Santos, Ivson Cassiano de Oliveira
    Carvalho-Assef, Ana Paula D'Alincourt
    BMC GENOMICS, 2020, 21 (01)
  • [35] Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells
    Chen, Yuxi
    Liu, Jiaqi
    Zhi, Shengyao
    Zheng, Qi
    Ma, Wenbin
    Huang, Junjiu
    Liu, Yizhi
    Liu, Dan
    Liang, Puping
    Zhou Songyang
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [36] Engineered minimal type I CRISPR-Cas system for transcriptional activation and base editing in human cells
    Guo, Jing
    Gong, Luyao
    Yu, Haiying
    Li, Ming
    An, Qiaohui
    Liu, Zhenquan
    Fan, Shuru
    Yang, Changjialian
    Zhao, Dahe
    Han, Jing
    Xiang, Hua
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [37] Reproducible Antigen Recognition by the Type I-F CRISPR-Cas System
    Wiegand, Tanner
    Semenova, Ekaterina
    Shiriaeva, Anna
    Fedorov, Ivan
    Datsenko, Kirill
    Severinov, Konstantin
    Wiedenheft, Blake
    CRISPR JOURNAL, 2020, 3 (05): : 378 - 387
  • [38] Type I-E CRISPR-Cas System as a Defense System in Saccharomyces cerevisiae
    Bindal, Gargi
    Amlinger, Lina
    Lundgren, Magnus
    Rath, Devashish
    MSPHERE, 2022, 7 (03)
  • [39] Discovery of widespread type I and type V CRISPR-Cas inhibitors
    Marino, Nicole D.
    Zhang, Jenny Y.
    Borges, Adair L.
    Sousa, Alexander A.
    Leon, Lina M.
    Rauch, Benjamin J.
    Walton, Russell T.
    Berry, Joel D.
    Joung, J. Keith
    Kleinstiver, Benjamin P.
    Bondy-Denomy, Joseph
    SCIENCE, 2018, 362 (6411) : 240 - 242
  • [40] Non-canonical inhibition strategies and structural basis of anti-CRISPR proteins targeting type I CRISPR-Cas systems
    Yin, Peipei
    Zhang, Yi
    Yang, Lingguang
    Feng, Yue
    JOURNAL OF MOLECULAR BIOLOGY, 2023, 435 (07)